Ratings by Lucid Capital Markets (Alex Nowak)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/24/2026 | Insight Molecular Diagnostics Inc. | IMDX | New Coverage | Buy (N/A) |
4.34 (3.84) |
-11.52% | Details | |
| 7/27/2026 | Envoy Medical | COCH | New Coverage | Buy (N/A) |
0.66 (0.70) |
6.06% | Details | |
| 6/3/2026 | SS Innovations Int'l | SSII | New Coverage | Buy (N/A) |
4.01 (3.34) |
-16.71% | Details | |
| 6/3/2026 | Microbot Medical | MBOT | New Coverage | Buy (N/A) |
2.01 (1.47) |
-26.87% | Details | |
| 6/3/2026 | Adagio Medical Holdings | ADGM | New Coverage | Buy (N/A) |
0.78 (0.51) |
-34.62% | Details |
